Explore more publications!
Health Network San Marino
Got News to Share?

Health Network San Marino: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Network San Marino.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on March 26, 2026

IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results
Mar. 26, 2026

IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results

Indeterminate GlobeNewswire
Iridex Reports Fourth Quarter and Full Year 2025 Financial Results
Mar. 26, 2026

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update
Mar. 26, 2026

Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update

Indeterminate GlobeNewswire
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Fourth Quarter 2025 Financial Results on March 31, 2026
Mar. 26, 2026

TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Fourth Quarter 2025 Financial Results on March 31, 2026

Indeterminate GlobeNewswire
Zentalis Pharmaceuticals Reports Full Year 2025 Financial Results and Operational Updates
Mar. 26, 2026

Zentalis Pharmaceuticals Reports Full Year 2025 Financial Results and Operational Updates

Indeterminate GlobeNewswire
Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly
Mar. 26, 2026

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly

Indeterminate GlobeNewswire
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results
Mar. 26, 2026

CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO
Mar. 26, 2026

Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO

Indeterminate GlobeNewswire
NurExone Strengthens U.S. Manufacturing Strategy Through Exo-Top Sublicense Agreement
Mar. 26, 2026

NurExone Strengthens U.S. Manufacturing Strategy Through Exo-Top Sublicense Agreement

Indeterminate GlobeNewswire
Galapagos Announces Nomination of Gino Santini to its Board of Directors
Mar. 26, 2026

Galapagos Announces Nomination of Gino Santini to its Board of Directors

Indeterminate GlobeNewswire
Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Mar. 26, 2026

Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Galapagos kondigt de voordracht aan van Gino Santini tot lid van de Raad van Bestuur
Mar. 26, 2026

Galapagos kondigt de voordracht aan van Gino Santini tot lid van de Raad van Bestuur

Indeterminate GlobeNewswire
Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings
Mar. 26, 2026

Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings

Indeterminate GlobeNewswire
Galapagos publiceert 2025 jaarverslag en kondigt de Gewone (jaarlijkse) en Buitengewone Algemene Vergaderingen aan
Mar. 26, 2026

Galapagos publiceert 2025 jaarverslag en kondigt de Gewone (jaarlijkse) en Buitengewone Algemene Vergaderingen aan

Indeterminate GlobeNewswire
SIGA Declares Special Cash Dividend of $0.60 Per Share
Mar. 26, 2026

SIGA Declares Special Cash Dividend of $0.60 Per Share

Indeterminate GlobeNewswire
Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update
Mar. 26, 2026

Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity
Mar. 26, 2026

Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity

Indeterminate GlobeNewswire
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $403 Million
Mar. 26, 2026

Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $403 Million

Indeterminate GlobeNewswire
Precision Optics Corporation, Inc. Announces Proposed Public Offering of Common Stock
Mar. 26, 2026

Precision Optics Corporation, Inc. Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock
Mar. 26, 2026

Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions